Real-World Use of Durvalumab Tremelimumab in Advanced HCC | OncLive
Real-World Use of Durvalumab Tremelimumab in Advanced HCC …
Oct 28, 2022
onclive.com
Treating for Stage III NSCLC After Progression on Durvalumab | OncLive
Treating for Stage III NSCLC After Progression on Durvalumab | Onc…
Jul 13, 2020
onclive.com
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC | OncLive
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
Highlights of Durvalumab for Advanced Bladder Cancer
Highlights of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metastatic NSCLC: 5-Year Overall Survival Update from the POSEIDON Study | OncLive
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…
Feb 26, 2024
onclive.com
7.8K views · 53 reactions | In patients with muscle-invasive bladder cancer, recurrences after standard treatment are common. Adding perioperative durvalumab to standard treatment may improve outcomes. Research findings are summarized in a new Quick Take video. Full research findings in comments. | The New England Journal of Medicine | Facebook
2:30
7.8K views · 53 reactions | In patients with muscle-invasive blad…
1.7K views1 week ago
FacebookThe New England Journal of Medicine
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial …
Jan 6, 2022
targetedonc.com
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
HIMALAYA Trial: First-Line Tremelimumab Plus Durvalumab I…
Oct 2, 2022
ascopost.com
Dr. Kato on the Rationale For Investigating Dato-DXd Plus Durv…
Sep 20, 2023
onclive.com
Updated Overall Survival from the Phase 3 TOPAZ-1 Study of Durval…
Jan 10, 2023
onclive.com
Dr. Halmos on the FDA Approval of Tremelimumab Plus Durvalumab a…
Nov 11, 2022
onclive.com
Dr Westin on the FDA Approval of Durvalumab Plus Chemo in dMM…
Aug 8, 2024
onclive.com
3:26
Immunotherapy Advances in SCLC: Unlocking Treatment Potential
3 months ago
YouTubeThe Shared Voice
Durvalumab plus bevacizumab, added to TACE, shows benefit for …
74 viewsFeb 20, 2024
YouTubeecancer
Pronunciation of the word(s) "Durvalumab".
4.8K viewsSep 25, 2020
YouTubeSAYTHEWORD-Learn English Pronunciations …
Durvalumab following chemoradiotherapy improves surv…
367 viewsJun 26, 2024
YouTubeecancer
The Use of Durvalumab in Locally Advanced NSCLC
281 viewsApr 16, 2018
YouTubeTargeted Oncology
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.5K viewsFeb 25, 2020
YouTubeTargeted Oncology
3:49
Preparing for Immunotherapy
NATIONALLY RATED HOSPITAL
About this channel
YouTubeFox Chase Cancer Center
1:32
Tecentriq (atezolizumab) approved to treat Advanced Bladder Cancer
5.5K viewsApr 18, 2017
YouTubemedXclusive Learning
1:20
How does PD-L1 impact treatment options for lung cancer?
14.2K viewsSep 14, 2020
YouTubeAmerican Lung Association
2:52
Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)
15.2K viewsAug 6, 2020
YouTubeYou and Lung Cancer
1:27
The Gallbladder and Bile Ducts | Cancer Research UK
378.5K viewsMay 13, 2019
YouTubeCancer Research UK
3:30
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
83K viewsAug 6, 2020
YouTubeYou and Lung Cancer
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab f…
5K viewsJun 20, 2017
YouTubeTargeted Oncology
1:08
Dr. Ku on Role of Durvalumab in Gastric Cancer
549 viewsApr 23, 2019
YouTubeOncLive
2:47
The Mechanism of Action of Immunotherapy for Cancer Treatm…
22.2K viewsJul 30, 2020
YouTubeScientific Animations
4:54
Getting My Life Back After Glioblastoma: Carol's Immunother…
43.8K viewsJun 5, 2017
YouTubeCancer Research Institute
1:06
The Mechanism of Action of Durvalumab in the Treatment of Ur…
1.5K viewsAug 10, 2016
YouTubeTargeted Oncology
See more videos
Static thumbnail place holder